S&P 500 7,706.03 −0.76%
Nasdaq 26,936.04 −0.69%
S&P/TSX 35,751.43 −0.72%
Apple 337.02 −0.80%
Nvidia 225.51 −1.47%
Microsoft 500.59 +0.52%
Shopify 200.46 +3.66%
Royal Bank 281.35 −2.86%
CAD/USD 0.7090 −0.27%
CLOSED · 02:05 ET
Market ClerkRecap
Thu Sep 24 · markets closed3 signals on Sep 23178 insider buys this week · $231.5MCIRO short report next: Sep 29The week ahead

NEOG

NEOGEN CORP
NASDAQ · HEALTH CARE · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
13.57
−0.04 −0.29%
USD · close Sep 23

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $3BP/E DIV YIELD FCF YIELD 1.08%REV TTM $870.4M −2.7%NET INCOME −$7.9MNET DEBT $608.2M52W 5.36 – 13.61SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 63 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q4 2026 · May 31derived$225.3M−0.1%47.8%$3.1M−$11.3M-0.06$30.2M$4M$26.2MJul 30
Q3 2026 · Feb 28$211.2M−4.4%46.9%−$3.3M−$17M-0.08$22.7M$11.6M$11.1MApr 9
Q2 2026 · Nov 30$224.7M−2.8%47.5%−$5.4M−$15.9M-0.07$19.4M$11.7M$7.8MJan 8
Q1 2026 · Aug 31$209.2M−3.6%45.4%−$16.1M$36.3M0.17$10.9M$24M−$13.1MOct 9
Q4 2025 · May 31derived$225.5M−4.8%41.2%−$611.2M−$612.2M-2.82$16.4M$16.1M$300KJul 30
Q3 2025 · Feb 28$221M−3.4%49.9%$5.4M−$10.9M-0.05$19.5M$32.9M−$13.4MApr 9
Q2 2025 · Nov 30$231.3M+0.7%49.0%−$457.5M−$456.3M-2.10$40.3M$17.2M$23.1MJan 8
Q1 2025 · Aug 31$217M−5.3%48.4%$2.3M−$12.6M−938.9%-0.06−$17.9M$38.4M−$56.3MOct 9
Q4 2024 · May 31derived$236.8M47.9%$13M−$5.4M-0.02$26.8M$24.2M$2.5MJul 30
Q3 2024 · Feb 29$228.8M51.1%$12M−$2M-0.01−$30.2M$32.1M−$62.3MApr 9
Q2 2024 · Nov 30$229.6M50.9%$14.5M−$3.5M-0.02$15.7M$24.4M−$8.7MJan 15
Q1 2024 · Aug 31$229M51.0%$19.1M$1.5M0.01$23M$30.6M−$7.6MOct 10

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2026 · to May 31$870.4M46.9%−$21.6M−$7.9M-0.9%-0.04$83.2M$51.3M$31.9M
FY2025 · to May 31$894.7M47.1%−$1.1B−$1.1B-122.1%-5.03$58.2M$104.6M−$46.4M
FY2024 · to May 31$924.2M50.2%$58.6M−$9.4M-1.0%-0.04$35.3M$111.4M−$76.1M
FY2023 · to May 31$822.4M49.4%$37.5M−$22.9M-2.8%-0.12$41M$65.8M−$24.7M
FY2022 · to May 31$527.2M46.1%$58.6M$48.3M9.2%0.45$68M$24.4M$43.6M
FY2021 · to May 31$468.5M45.9%$74.2M$60.9M13.0%0.57$81.1M$26.7M$54.4M

Every number comes from NEOGEN CORP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch NEOG. Know when insiders buy.
One email the day a filing lands. Free.